加味资生丸治疗脾肾阳虚型肝硬化腹水临床观察  被引量:5

Clinical Observation of Zisheng Pill in Treatment of Spleen and Kidney Yang Deficiency Type of Cirrhosis Ascites

在线阅读下载全文

作  者:王小锋[1] 马文军[2] 侯宝峰[2] 

机构地区:[1]陕西中医学院,陕西咸阳712000 [2]陕西中医学院附属医院肝病科,陕西咸阳712000

出  处:《辽宁中医药大学学报》2014年第4期198-200,共3页Journal of Liaoning University of Traditional Chinese Medicine

摘  要:目的:观察加味资生丸治疗脾肾阳虚型肝硬化腹水患者的临床疗效。方法:将70例肝硬化腹水患者随机分为对照组和治疗组各35例。两组均采用西医基础治疗方案,治疗组加用加味资生丸,每次6?g,每日3次,4周为1个疗程,治疗2个疗程。比较两组患者治疗前后血清白蛋白变化、白/球比值、中医证候积分、生活质量评分。结果:与治疗前比较,两组患者用药后血清白蛋白含量、白/球比值、中医证候积分、生活质量评分均有改善。与对照组比较,治疗组用药后患者血清白蛋白含量、白/球比值、中医证候积分、生活质量评分均改善明显,差异有统计学意义(P<0.05)。结论:加味资生丸治疗脾肾阳虚型肝硬化腹水疗效显著,值得临床推广应用。Objective : To observe the clinical efficacy of Zisheng Pill in the treatment of spleen and kidney yang deficiency type cirrhosis ascites. Methods : 70 patients with spleen and kidney yang deficiency type cirrhosis ascites were randomly divided into the control group and the treatment group (n=35). Two groups both used western medicine foundation treatment, and the treatment group added Zisheng Pill, 6 grams for each time, 3 times a day, 4 weeks as a course, treating for 2 course. Two groups serum albumin change, white/ball ratio, TCM syndrome integral, quality of life scores were compared before and after treatment. Results : Compared with those before treatment, two groups patients serum albumin content, ratio of white/ball, the TCM syndrome integral and quality of life score were improved. Compared with control group, treatment group after medication, patients' serum albumin content, ratio of white/ ball, the TCM syndrome integral, quality of life scores were improved significantly, the difference was statistically significant ( P〈0.05 ). Conclusion : Zisheng Pill in the treatment of spleen and kidney yang deficiency type cirrhosis ascites has obvious therapeutic effect, and is worthy of clinical popularization and application.

关 键 词:加味资生丸 肝硬化腹水 中医证候积分 生活质量评分 

分 类 号:R657.31[医药卫生—外科学] R442.5[医药卫生—临床医学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象